Sign in

CIK 0001437402

  • Large accelerated filer

ARDELYX, INC.

Sign in to watch
Ticker
ARDX
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 510-745-7047
Business address
34175 ARDENWOOD BLVD., FREMONT, CA, 94555
Former names
NTERYX INC
  1. 4 Planned sale President & CEO sold 41,666 shares at $5.36 ($223,355)
  2. 4 Open-market buy Director bought 199,000 shares at $4.99 ($992,672)
  3. 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
  4. 4 Planned sale President & CEO sold 41,666 shares at $5.31 ($221,309)
  5. 4 Exercise or conversion Director acquired 100,000 shares (option exercise)
  6. 4 Open-market buy Director bought 213,300 shares at $4.67 ($996,580)
  7. 4 Planned sale President & CEO sold 25,000 shares at $5.26 ($131,620)
  8. 4 Planned sale President & CEO sold 25,000 shares at $5.38 ($134,483)
  9. 4 Open-market sale Chief Medical Officer sold 7,366 shares at $4.79 ($35,316)
  10. 4 Open-market sale Chief Development Officer sold 7,184 shares at $4.79 ($34,444)
  11. 4 Open-market sale Chief Financial Officer sold 5,260 shares at $4.79 ($25,219)
  12. 4 Open-market sale President & CEO sold 31,980 shares at $4.79 ($153,328)
  13. 4 Open-market sale GRAMMER ELIZABETH A sold 7,046 shares at $4.79 ($33,782)
  14. 4 Open-market sale Blanks Robert sold 4,941 shares at $4.79 ($23,690)
  15. 3 Insider Initial Statement of Ownership
  16. 4 Open-market buy Director bought 215,868 shares at $4.62 ($996,598)
  17. 4 Planned sale President & CEO sold 2,743 shares at $4.90 ($13,441)
  18. 4 Open-market sale Chief Development Officer sold 27,171 shares at $6.10 ($165,743)
  19. 4 Open-market sale Chief Development Officer sold 27,172 shares at $5.95 ($161,673)
  20. 4 Planned sale President & CEO sold 25,000 shares at $5.91 ($147,740)

Page 6 of 35 · 690 filings